[Retracted] Clinical Observation of Ropinirole Hydrochloride in the Treatment of Parkinson’s Disease

Table 2

Major pharmacokinetic parameters for different doses of ropinirole patients.

	1.5 mg	1 mg	0.5 mg	0.2 mg
Elimination half-life	1.39	1.49	1.84	1.97
Peak time	0.5	0.64	0.96	1.02
Peak concentration	9.54	24.95	5.82	1.19
Average residence time	1.72	2.05	2.24	2.35
Clearance rate	104.69	143.42	124.45	129.26